Behavioral Determinants of Cannabinoid Self-Administration in Old World Monkeys.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

1. Pharmacokinetics of oral Δ9-tetrahydrocannabinol (THC) administration in vervet monkeys.Journal of cannabis research · 2026
   Article
2. Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models.Current topics in behavioral neurosciences · 2026
   Review
3. Cannabis Unveiled: An Exploration of Marijuana's History, Active Compounds, Effects, Benefits, and Risks on Human Health.Substance abuse : research and treatment · 2023
   Review
4. Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge.Cells · 2022
   Review
5. Self-administration of inhaled delta-9-tetrahydrocannabinol and synthetic cannabinoids in non-human primates.Experimental and clinical psychopharmacology · 2021
   Article
6. Factors mediating pain-related risk for opioid use disorder.Neuropharmacology · 2021
   Review
7. Dissecting the role of CBEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2021
   Article
8. Interactions between opioids and cannabinoids: Economic demand for opioid/cannabinoid mixtures.Drug and alcohol dependence · 2020
   Article
9. Molecular Mechanism and Cannabinoid Pharmacology.Handbook of experimental pharmacology · 2020
   Article
10. Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.CNS drugs · 2019
    Review
11. Cannabinoid CBBritish journal of pharmacology · 2019
    Article
12. Effects of repeated treatment with methcathinone, mephedrone, and fenfluramine on intracranial self-stimulation in rats.Psychopharmacology · 2019
    Article
13. Progress in brain cannabinoid CBNeuroscience and biobehavioral reviews · 2019
    Review
14. Determinants of opioid abuse potential: Insights using intracranial self-stimulation.Peptides · 2019
    Review
15. Chronic ΔThe Journal of pharmacology and experimental therapeutics · 2018
    Article
16. Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Review
17. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and ΔNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Review
18. Mechanisms Underlying Sex Differences in Cannabis Use.Current addiction reports · 2017
    Article
19. Utility of Nonhuman Primates in Substance Use Disorders Research.ILAR journal · 2017
    Review
20. CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies ΔScientific reports · 2017
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors at 1 institution in 1 country.

Funding

Abstract

Indexed as